SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2.
作者信息
Wu Leyun, Zhou Liping, Mo Mengxia, Liu Tingting, Wu Chengkun, Gong Chunye, Lu Kai, Gong Likun, Zhu Weiliang, Xu Zhijian
机构信息
CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
College of Computer Science and Technology, National University of Defense Technology, Changsha, 410073, China.
出版信息
Signal Transduct Target Ther. 2022 Jan 5;7(1):8. doi: 10.1038/s41392-021-00863-2.
Abstract
摘要
Zotero 插件